A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT06873945 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Ritlecitinib 100 mg
DRUG: Ritlecitinib 50 mg
DRUG: Placebo - 100 mg
DRUG: Placebo - 50 mg

Sponsor

Pfizer